Posted in | News

QuikClot NoseBleed Offers Consumers Simple and Effective First Aid to Stop Bleeding Fast

Every year in the United States, there are close to 400 million nosebleeds. While many nosebleeds are minor, about 515,000 result in visits to hospital emergency departments(1) -- stressful, time consuming and expensive incidents. Nosebleeds occur most frequently in two age groups, children two to ten years old, and seniors. Z-Medica Corp is now making a difference for mothers and caregivers to these loved ones with QuikClot® NoseBleed™ brand, a safe and economical new way to stop nasal bleeding.

QuikClot® NoseBleed™ brand, a gauze packing impregnated with a specially formulated substance that activates factors in blood to promote rapid blood coagulation, comes in an easy to apply and easy to remove format. It has been cleared by the FDA for over-the-counter use by anyone who can follow simple directions.

The packing is rolled or folded to fit into the affected nostril. Once inserted, pressure is applied and the bleeding should stop quickly. The new product is available online at http://www.quikclot.com where the Manufacturer's Suggested Retail Price (MSRP) for a box of five sterile applications is $11.49.

QuikClot® NoseBleed™ brand is manufactured by Z-Medica Corporation, a medical products company focused on innovative hemostatic nano-technologies. The company manufactures and markets several other life-saving products for use by its original markets -- the military, first responders, industrial first aid teams and law enforcement personnel. In addition to this new generation consumer product, the company also now offers online at http://www.quikclot.com other consumer products that stop bleeding for home, travel, sport and pet use. Z-Medica Corp headquarters is located at 4 Fairfield Blvd., Wallingford, Connecticut 06492. For more information, please call (203) 294-0000 or visit http://www.z-medica.com.

(1) Epidemiology of Epistaxis in US Emergency Departments, 1992 to 2001. Annals of Emergency Medicine, Volume 46, Issue 1, July 2005, Pages 77-81

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.